Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0015 | 1 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |